The HIV-1 accessory gene vpr can inhibit antigen-specific immune function

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• The human immunodeficiency virus type 1 (HIV-1) accessory gene, Vpr, is known to affect host cell biology, including cell proliferation and apoptosis.
• Reported Vpr activities suggest a potential impact on host immune responses, particularly T-cell function.

Purpose of the Study:

• To investigate the in vitro and in vivo effects of the HIV-1 Vpr protein on T-cell activation and immune responses.
• To develop and utilize an Adenoviral Vpr expression vector for studying Vpr function in immune cells.

Main Methods:

• Recombinant Vpr protein was used to test its inhibitory effects on T-cell activation in vitro.
• Covaccination with plasmids expressing Vpr was employed to assess in vivo effects on cytotoxic T lymphocyte (CTL) activity.
• An Adenoviral Vpr expression vector was developed to deliver Vpr to immune cells, including antigen-presenting cells (APCs), for functional studies.

Main Results:

• Recombinant Vpr protein significantly suppressed T-cell activation-related cytokine production and proliferation in vitro.
• In vivo, Vpr expression via covaccination markedly reduced antigen-specific CD8-mediated CTL activity.
• The Adeno-Vpr vector demonstrated suppression of human CD4 T-cell proliferation upon immune activation in vitro.

Conclusions:

• The HIV-1 Vpr protein plays a significant role in suppressing T-cell immunity, both in vitro and in vivo.
• Vpr may compromise host immune responses during HIV-1 infection.
• Understanding Vpr's biological functions is crucial for insights into HIV pathogenesis and the development of effective HIV vaccines.